Nanomedicine Market 2019
This report focuses on the global Nanomedicine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nanomedicine development in United States, Europe and China.
Nanomedicine is the medical application of nanotechnology.Nanomedicine ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines.
As per the WHO factsheet, cancer is found to be one of the major causes of mortality and morbidity worldwide, with approximately 14 million new cases in 2012 and 8.2 million cancer-related deaths. Thus, demand for nanomedicine in order to curb such high incidence rate is expected to boost market progress during the forecast period.
Potential pipeline of products based on the nanomolecules and associated technologies are anticipated to drive market with potential avenues of growth. Presence of around 40% of products in phase II of clinical development, is anticipated to result in a number of key commercialization over the coming decade influencing revenue generation over the forecast period. The customized treatment options available for eradication of genetic abnormalities also makes this technology a substantial option for precision medicine.
Asia Pacific is expected to witness lucrative growth through to 2025 as a result of rise in number of research grants and increase in demand for prophylaxis of life-threatening diseases. Moreover, rise in the number of venture capital investors from developing economies of this region and increasing international research collaborations are anticipated to propel growth in nanotechnology-based healthcare industry.
Request Free Sample Report @ https://www.wiseguyreports.com/sample-request/3355542-global-nanomedicine-market-size-status-and-forecast-2018-2025
The key players covered in this study
Combimatrix
Ablynx
Abraxis Bioscience
Celgene
Mallinckrodt
Arrowhead Research
GE Healthcare
Merck
Pfizer
Nanosphere
Epeius Biotechnologies
Cytimmune Sciences
Nanospectra Biosciences
Market segment by Type, the product can be split into
Quantum dots
Nanoparticles
Nanoshells
Nanotubes
Nanodevices
Market segment by Application, split into
Segmentation encompasses oncology
Infectious diseases
Cardiology
Orthopedics
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
Complete Report Details @ https://www.wiseguyreports.com/reports/3355542-global-nanomedicine-market-size-status-and-forecast-2018-2025
Table of Contents –Analysis of Key Points
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Nanomedicine Market Size Growth Rate by Type (2013-2025)
1.4.2 Quantum dots
1.4.3 Nanoparticles
1.4.4 Nanoshells
1.4.5 Nanotubes
1.4.6 Nanodevices
1.5 Market by Application
1.5.1 Global Nanomedicine Market Share by Application (2013-2025)
1.5.2 Segmentation encompasses oncology
1.5.3 Infectious diseases
1.5.4 Cardiology
1.5.5 Orthopedics
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Nanomedicine Market Size
2.2 Nanomedicine Growth Trends by Regions
2.2.1 Nanomedicine Market Size by Regions (2013-2025)
2.2.2 Nanomedicine Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Nanomedicine Market Size by Manufacturers
3.1.1 Global Nanomedicine Revenue by Manufacturers (2013-2018)
3.1.2 Global Nanomedicine Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Nanomedicine Market Concentration Ratio (CR5 and HHI)
3.2 Nanomedicine Key Players Head office and Area Served
3.3 Key Players Nanomedicine Product/Solution/Service
3.4 Date of Enter into Nanomedicine Market
3.5 Mergers & Acquisitions, Expansion Plans
…….
12 International Players Profiles
12.1 Combimatrix
12.1.1 Combimatrix Company Details
12.1.2 Company Description and Business Overview
12.1.3 Nanomedicine Introduction
12.1.4 Combimatrix Revenue in Nanomedicine Business (2013-2018)
12.1.5 Combimatrix Recent Development
12.2 Ablynx
12.2.1 Ablynx Company Details
12.2.2 Company Description and Business Overview
12.2.3 Nanomedicine Introduction
12.2.4 Ablynx Revenue in Nanomedicine Business (2013-2018)
12.2.5 Ablynx Recent Development
12.3 Abraxis Bioscience
12.3.1 Abraxis Bioscience Company Details
12.3.2 Company Description and Business Overview
12.3.3 Nanomedicine Introduction
12.3.4 Abraxis Bioscience Revenue in Nanomedicine Business (2013-2018)
12.3.5 Abraxis Bioscience Recent Development
12.4 Celgene
12.4.1 Celgene Company Details
12.4.2 Company Description and Business Overview
12.4.3 Nanomedicine Introduction
12.4.4 Celgene Revenue in Nanomedicine Business (2013-2018)
12.4.5 Celgene Recent Development
12.5 Mallinckrodt
12.5.1 Mallinckrodt Company Details
12.5.2 Company Description and Business Overview
12.5.3 Nanomedicine Introduction
12.5.4 Mallinckrodt Revenue in Nanomedicine Business (2013-2018)
12.5.5 Mallinckrodt Recent Development
12.6 Arrowhead Research
12.6.1 Arrowhead Research Company Details
12.6.2 Company Description and Business Overview
12.6.3 Nanomedicine Introduction
12.6.4 Arrowhead Research Revenue in Nanomedicine Business (2013-2018)
12.6.5 Arrowhead Research Recent Development
12.7 GE Healthcare
12.7.1 GE Healthcare Company Details
12.7.2 Company Description and Business Overview
12.7.3 Nanomedicine Introduction
12.7.4 GE Healthcare Revenue in Nanomedicine Business (2013-2018)
12.7.5 GE Healthcare Recent Development
12.8 Merck
12.8.1 Merck Company Details
12.8.2 Company Description and Business Overview
12.8.3 Nanomedicine Introduction
12.8.4 Merck Revenue in Nanomedicine Business (2013-2018)
12.8.5 Merck Recent Development
12.9 Pfizer
12.9.1 Pfizer Company Details
12.9.2 Company Description and Business Overview
12.9.3 Nanomedicine Introduction
12.9.4 Pfizer Revenue in Nanomedicine Business (2013-2018)
12.9.5 Pfizer Recent Development
12.10 Nanosphere
12.10.1 Nanosphere Company Details
12.10.2 Company Description and Business Overview
12.10.3 Nanomedicine Introduction
12.10.4 Nanosphere Revenue in Nanomedicine Business (2013-2018)
12.10.5 Nanosphere Recent Development
Continued…..
Media Contact
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349
City: Pune
State: Maharashtra
Country: India
Website: www.wiseguyreports.com